


Searching News Database: Johnson & Johnson
Your search returned too many results! The most recent 500 items are shown below:
HSMN NewsFeed - 19 Jun 2025
Johnson & Johnson Launches VOLT(TM) Wrist and Proximal Humerus Plating Systems in the U.S.
Johnson & Johnson Launches VOLT(TM) Wrist and Proximal Humerus Plating Systems in the U.S.
HSMN NewsFeed - 12 Dec 2024
U.S. FDA Expands Indication for Impella Heart Pumps to Treat Pediatric Patients
U.S. FDA Expands Indication for Impella Heart Pumps to Treat Pediatric Patients
HSMN NewsFeed - 23 Oct 2024
Alphina Therapeutics Appoints Veteran Biotech Executive, Nick Galli, as Chief Executive Officer
Alphina Therapeutics Appoints Veteran Biotech Executive, Nick Galli, as Chief Executive Officer
HSMN NewsFeed - 7 Nov 2023
Johnson & Johnson MedTech Provides Details and Timeline for General Surgery Robot
Johnson & Johnson MedTech Provides Details and Timeline for General Surgery Robot
HSMN NewsFeed - 27 Jun 2023
SonoThera(TM) Expands Leadership Team Appointing Carolyne Zimmermann as Chief Business Officer
SonoThera(TM) Expands Leadership Team Appointing Carolyne Zimmermann as Chief Business Officer
HSMN NewsFeed - 5 Jan 2023
Perceive Biotherapeutics Attracts $78M Series B Financing to Advance Diversified Pipeline
Perceive Biotherapeutics Attracts $78M Series B Financing to Advance Diversified Pipeline
HSMN NewsFeed - 6 Jun 2022
Ethicon Launches Next Generation Echelon(TM) 3000 Stapler Designed for Exceptional Access and Control
Ethicon Launches Next Generation Echelon(TM) 3000 Stapler Designed for Exceptional Access and Control
HSMN NewsFeed - 9 Mar 2022
Orna Therapeutics Bolsters Leadership Team with Key Executive and Board Appointments
Orna Therapeutics Bolsters Leadership Team with Key Executive and Board Appointments
HSMN NewsFeed - 16 Nov 2021
Sonendo Announces Alma Salazar as Associate Vice President, Professional and Consumer Marketing
Sonendo Announces Alma Salazar as Associate Vice President, Professional and Consumer Marketing
HSMN NewsFeed - 21 Jun 2021
Ethicon Expands Advanced Biopolar Energy Portfolio With Launch Of ENSEAL X1 Curved Jaw Tissue Sealer
Ethicon Expands Advanced Biopolar Energy Portfolio With Launch Of ENSEAL X1 Curved Jaw Tissue Sealer
HSMN NewsFeed - 1 Jun 2021
Neurana Pharmaceuticals Appoints Georgia Erbez and Liz Cermak to Board of Directors
Neurana Pharmaceuticals Appoints Georgia Erbez and Liz Cermak to Board of Directors
HSMN NewsFeed - 31 Mar 2021
Zimmer Biomet Announces Key Updates to Company's Executive Leadership Team
Zimmer Biomet Announces Key Updates to Company's Executive Leadership Team
HSMN NewsFeed - 26 Jan 2021
Scott Huennekens joins 270Surgical Board of Directors, Observer and Advisor
Scott Huennekens joins 270Surgical Board of Directors, Observer and Advisor
HSMN NewsFeed - 30 Oct 2020
Senior Leadership Appointments at TrackX Technology, Inc. : Ray Oktavec & Chris Helps
Senior Leadership Appointments at TrackX Technology, Inc. : Ray Oktavec & Chris Helps
HSMN NewsFeed - 23 Sep 2020
Johnson & Johnson Initiates Pivotal Global Phase 3 Clinical Trial of Janssen's COVID-19 Vaccine Candidate
Johnson & Johnson Initiates Pivotal Global Phase 3 Clinical Trial of Janssen's COVID-19 Vaccine Candidate
HSMN NewsFeed - 19 May 2020
BioEclipse Therapeutics(TM) Announces Move to New Corporate Headquarters in Mountain View, CA
BioEclipse Therapeutics(TM) Announces Move to New Corporate Headquarters in Mountain View, CA
HSMN NewsFeed - 10 Feb 2020
Enteris BioPharma Appoints Gary A. Shangold, MD, as Chief Medical Officer
Enteris BioPharma Appoints Gary A. Shangold, MD, as Chief Medical Officer
HSMN NewsFeed - 10 Feb 2020
CollPlant Announces Appointment of Roger J. Pomerantz, M.D., F.A.C.P. as Chairman of the Board of Directors
CollPlant Announces Appointment of Roger J. Pomerantz, M.D., F.A.C.P. as Chairman of the Board of Directors
HSMN NewsFeed - 20 Dec 2019
Johnson & Johnson Announces Agreement to Acquire Remaining Stake in Verb Surgical Inc.
Johnson & Johnson Announces Agreement to Acquire Remaining Stake in Verb Surgical Inc.
HSMN NewsFeed - 19 Sep 2019
Vivex Biologics, Inc. Announces Peter Wehrly as the New CEO of the Company
Vivex Biologics, Inc. Announces Peter Wehrly as the New CEO of the Company
HSMN NewsFeed - 12 Aug 2019
binx health Receives FDA 510(k) Clearance For Rapid Point Of Care Platform For Women's Health
binx health Receives FDA 510(k) Clearance For Rapid Point Of Care Platform For Women's Health
HSMN NewsFeed - 24 Jun 2019
BioEclipse Therapeutics(TM) Announces Appointment of New Directors and Series A-1 Financing
BioEclipse Therapeutics(TM) Announces Appointment of New Directors and Series A-1 Financing
HSMN NewsFeed - 8 Apr 2019
HistoSonics, Non-Invasive Robotics Pioneer, Closes $54 Million Series C Financing
HistoSonics, Non-Invasive Robotics Pioneer, Closes $54 Million Series C Financing
HSMN NewsFeed - 28 Mar 2019
Hyalex Orthopaedics, synthetic cartilage company, adds new funding; expanding Series A total to $33MM
Hyalex Orthopaedics, synthetic cartilage company, adds new funding; expanding Series A total to $33MM
HSMN NewsFeed - 23 Jul 2018
OrthoSpin Ltd. Completes $3 Million Raise for Orthopedic Robotic External Fixation System
OrthoSpin Ltd. Completes $3 Million Raise for Orthopedic Robotic External Fixation System
HSMN NewsFeed - 16 Jul 2018
enGene Appoints Veteran Life Sciences Executive Jason D. Hanson as Chief Executive Officer and President
enGene Appoints Veteran Life Sciences Executive Jason D. Hanson as Chief Executive Officer and President
HSMN NewsFeed - 21 May 2018
CERENOVUS Receives FDA Clearance For Next Generation Stent Retriever Device Used To Treat Ischemic Stroke
CERENOVUS Receives FDA Clearance For Next Generation Stent Retriever Device Used To Treat Ischemic Stroke
HSMN NewsFeed - 8 May 2018
TFF Pharmaceuticals Announces Appointment of Glenn Mattes as New Chief Executive Officer
TFF Pharmaceuticals Announces Appointment of Glenn Mattes as New Chief Executive Officer
HSMN NewsFeed - 5 Apr 2018
Former Acelity, J&J Executive Joins Organogenesis as Vice President of Global Medical & Clinical Affairs
Former Acelity, J&J Executive Joins Organogenesis as Vice President of Global Medical & Clinical Affairs
HSMN NewsFeed - 16 Mar 2018
Johnson & Johnson Announces Binding Offer from Platinum Equity to Acquire LifeScan, Inc.
Johnson & Johnson Announces Binding Offer from Platinum Equity to Acquire LifeScan, Inc.
HSMN NewsFeed - 27 Feb 2018
Senti Biosciences Secures $53 Million Series A to Build the Future of Gene and Cell-Based Therapies
Senti Biosciences Secures $53 Million Series A to Build the Future of Gene and Cell-Based Therapies
HSMN NewsFeed - 13 Feb 2018
Aptinyx Appoints Ashish Khanna Chief Financial Officer and Chief Business Officer
Aptinyx Appoints Ashish Khanna Chief Financial Officer and Chief Business Officer
HSMN NewsFeed - 23 Oct 2017
EMD Serono Appoints Robert Truckenmiller to Senior Vice President of Market Access & Customer Solutions
EMD Serono Appoints Robert Truckenmiller to Senior Vice President of Market Access & Customer Solutions
HSMN NewsFeed - 4 Oct 2017
New Breast Implant For Patients Undergoing Breast Reconstruction, Augmentation Or Revision Surgery
New Breast Implant For Patients Undergoing Breast Reconstruction, Augmentation Or Revision Surgery
HSMN NewsFeed - 4 Oct 2017
Boston Scientific Appoints Desiree Ralls-Morrison General Counsel and Corporate Secretary
Boston Scientific Appoints Desiree Ralls-Morrison General Counsel and Corporate Secretary
HSMN NewsFeed - 20 Sep 2017
DURECT Appoints Dr. Myriam Theeuwes as Senior Vice President, Clinical Development
DURECT Appoints Dr. Myriam Theeuwes as Senior Vice President, Clinical Development
HSMN NewsFeed - 7 Sep 2017
Vividion Therapeutics Appoints Diego Miralles, M.D., Chief Executive Officer
Vividion Therapeutics Appoints Diego Miralles, M.D., Chief Executive Officer
HSMN NewsFeed - 21 Aug 2017
Ethicon Launches ProxiSure(TM) Suturing Device Designed To Improve Precision In Minimally-Invasive Surgery
Ethicon Launches ProxiSure(TM) Suturing Device Designed To Improve Precision In Minimally-Invasive Surgery
HSMN NewsFeed - 12 Jul 2017
E-Scape Bio Series A Extension Brings Total Round to $63 Million to Fund Neurodegenerative Disease Pipeline
E-Scape Bio Series A Extension Brings Total Round to $63 Million to Fund Neurodegenerative Disease Pipeline
HSMN NewsFeed - 27 Jun 2017
DePuy Synthes Announces Acquisition of Sentio, LLC to Enable Innovation in Minimally Invasive Spine Surgery
DePuy Synthes Announces Acquisition of Sentio, LLC to Enable Innovation in Minimally Invasive Spine Surgery
HSMN NewsFeed - 31 May 2017
Hyalex Orthopaedics Raises $16 Million Series A Financing and Appoints Chief Executive Officer
Hyalex Orthopaedics Raises $16 Million Series A Financing and Appoints Chief Executive Officer
HSMN NewsFeed - 24 May 2017
DERMABOND(R) PRINEO(R) Skin Closure System May Improve Outcomes and Lower Hospital Costs
DERMABOND(R) PRINEO(R) Skin Closure System May Improve Outcomes and Lower Hospital Costs
HSMN NewsFeed - 15 May 2017
BiomX Raises $24 Million in Series A Funding to Develop Microbiome Therapeutics
BiomX Raises $24 Million in Series A Funding to Develop Microbiome Therapeutics
HSMN NewsFeed - 20 Apr 2017
DePuy Synthes Acquires Tissue Regeneration System's 3D Printing Technologies to Treat Bone Defects
DePuy Synthes Acquires Tissue Regeneration System's 3D Printing Technologies to Treat Bone Defects
HSMN NewsFeed - 19 Apr 2017
Ethicon Announces 510(k) Clearance For ECHELON CIRCULAR(TM) Powered Stapler
Ethicon Announces 510(k) Clearance For ECHELON CIRCULAR(TM) Powered Stapler
HSMN NewsFeed - 29 Mar 2017
Tyme Technologies Announces Two New Board of Director Appointments -- David Carberry and James Biehl
Tyme Technologies Announces Two New Board of Director Appointments -- David Carberry and James Biehl
HSMN NewsFeed - 22 Mar 2017
AntriaBio Appoints Two Pharmaceutical Executives to its Board of Directors
AntriaBio Appoints Two Pharmaceutical Executives to its Board of Directors
HSMN NewsFeed - 25 Jan 2017
DePuy Synthes Announces Exclusive Co-Promotional Agreement with Pacira Pharmaceuticals, Inc.
DePuy Synthes Announces Exclusive Co-Promotional Agreement with Pacira Pharmaceuticals, Inc.
HSMN NewsFeed - 8 Dec 2016
Agenovir Appoints Industry Veteran Dirk Thye, M.D. As Chief Executive Officer
Agenovir Appoints Industry Veteran Dirk Thye, M.D. As Chief Executive Officer
HSMN NewsFeed - 27 Jul 2016
FloShield Significantly Reduces Robotic Laparoscope Lens Removals During Surgery
FloShield Significantly Reduces Robotic Laparoscope Lens Removals During Surgery
HSMN NewsFeed - 20 Jul 2016
Acclarent Announces U.S. Launch of RELIEVA SCOUT(R) Multi-Sinus Dilation System
Acclarent Announces U.S. Launch of RELIEVA SCOUT(R) Multi-Sinus Dilation System
HSMN NewsFeed - 20 Jul 2016
Juniper Pharmaceuticals Appoints Alicia Secor President and Chief Executive Officer
Juniper Pharmaceuticals Appoints Alicia Secor President and Chief Executive Officer
HSMN NewsFeed - 6 Jun 2016
Vedanta Biosciences Closes $50 Million Financing to Advance Microbiome Therapeutics
Vedanta Biosciences Closes $50 Million Financing to Advance Microbiome Therapeutics
HSMN NewsFeed - 24 May 2016
Amplyx Pharmaceuticals Appoints Paul C. Grint, M.D., to Board of Directors
Amplyx Pharmaceuticals Appoints Paul C. Grint, M.D., to Board of Directors
HSMN NewsFeed - 28 Mar 2016
First Human Results with V-Wave’s Interatrial Shunt Published in The Lancet
First Human Results with V-Wave’s Interatrial Shunt Published in The Lancet
HSMN NewsFeed - 17 Feb 2016
New OneTouch Verio Flex(TM) Blood Glucose Meter Takes the Guesswork Out of Blood Sugar Test Results
New OneTouch Verio Flex(TM) Blood Glucose Meter Takes the Guesswork Out of Blood Sugar Test Results
HSMN NewsFeed - 16 Feb 2016
Carmell Therapeutics Announces Appointment of Randy Hubbell to President and Chief Executive Officer
Carmell Therapeutics Announces Appointment of Randy Hubbell to President and Chief Executive Officer
HSMN NewsFeed - 9 Feb 2016
Amplyx Pharmaceuticals Expands Management Team and Increases Its Series B Financing to $49.2 Million
Amplyx Pharmaceuticals Expands Management Team and Increases Its Series B Financing to $49.2 Million
HSMN NewsFeed - 11 Jan 2016
FDA Approves Animas(R) Vibe(R) Insulin Pump and Continuous Glucose Monitoring System For Use in Children
FDA Approves Animas(R) Vibe(R) Insulin Pump and Continuous Glucose Monitoring System For Use in Children
HSMN NewsFeed - 29 Oct 2015
BioPharmX Corporation Names AnnaMarie Daniels Executive Vice President of Clinical and Regulatory Affairs
BioPharmX Corporation Names AnnaMarie Daniels Executive Vice President of Clinical and Regulatory Affairs
HSMN NewsFeed - 27 Oct 2015
Mirna Therapeutics Appoints Dr. Miguel Barbosa as Executive Vice President and Chief Scientific Officer
Mirna Therapeutics Appoints Dr. Miguel Barbosa as Executive Vice President and Chief Scientific Officer
HSMN NewsFeed - 21 Oct 2015
Head Janssen Neuroscientist Appointed to Scientific Advisory Board of Global Dementia Discovery Fund
Head Janssen Neuroscientist Appointed to Scientific Advisory Board of Global Dementia Discovery Fund
HSMN NewsFeed - 16 Oct 2015
Johnson & Johnson Announces Start of Clinical Trial of Ebola Vaccine Regimen in Sierra Leone
Johnson & Johnson Announces Start of Clinical Trial of Ebola Vaccine Regimen in Sierra Leone
HSMN NewsFeed - 1 Sep 2015
SI-BONE, Inc. Appoints Karen Licitra and Keith Valentine to its Board of Directors
SI-BONE, Inc. Appoints Karen Licitra and Keith Valentine to its Board of Directors
HSMN NewsFeed - 5 Aug 2015
InteloMed, Inc. Appoints Jill Schiaparelli President and Chief Executive Officer
InteloMed, Inc. Appoints Jill Schiaparelli President and Chief Executive Officer
HSMN NewsFeed - 1 Jul 2015
GlySure Secures CE Mark and Launches World’s First Continuous Intravascular Glucose Monitoring System
GlySure Secures CE Mark and Launches World’s First Continuous Intravascular Glucose Monitoring System
HSMN NewsFeed - 8 May 2015
Armetheon, Inc. Announces Appointment of Andrew C. Lam as Vice President of Product Development
Armetheon, Inc. Announces Appointment of Andrew C. Lam as Vice President of Product Development
HSMN NewsFeed - 21 Apr 2015
IlluminOss Medical Appoints Amy Orlick Berman as Vice President of Clinical Affairs
IlluminOss Medical Appoints Amy Orlick Berman as Vice President of Clinical Affairs
HSMN NewsFeed - 14 Apr 2015
Infinity Augments Executive Leadership Team, Appointing Chief Commercial Officer and General Counsel
Infinity Augments Executive Leadership Team, Appointing Chief Commercial Officer and General Counsel
HSMN NewsFeed - 17 Feb 2015
Boston Scientific Announces Agreement With Johnson & Johnson To Resolve Guidant Litigation
Boston Scientific Announces Agreement With Johnson & Johnson To Resolve Guidant Litigation
HSMN NewsFeed - 5 Jan 2015
Catalyst Pharmaceuticals Appoints David D. Muth, Executive Vice President, Chief Commercial Officer
Catalyst Pharmaceuticals Appoints David D. Muth, Executive Vice President, Chief Commercial Officer
HSMN NewsFeed - 4 Sep 2014
Catalyst Pharmaceuticals Appoints David D. Muth as Executive Vice President, Corporate Development
Catalyst Pharmaceuticals Appoints David D. Muth as Executive Vice President, Corporate Development
HSMN NewsFeed - 11 Aug 2014
Auxilium Pharmaceuticals, Inc. Appoints Andrew Saik Chief Financial Officer
Auxilium Pharmaceuticals, Inc. Appoints Andrew Saik Chief Financial Officer
HSMN NewsFeed - 6 Aug 2014
Nodality Expands Senior Leadership Team, Appoints Kathleen LaPorte as Chief Business Officer
Nodality Expands Senior Leadership Team, Appoints Kathleen LaPorte as Chief Business Officer
HSMN NewsFeed - 26 Jun 2014
Tris Pharma Expands R&D Team with addition of Chief Medical Officer and Vice President of Regulatory Affairs
Tris Pharma Expands R&D Team with addition of Chief Medical Officer and Vice President of Regulatory Affairs
HSMN NewsFeed - 24 Jun 2014
Covidien Files Patent Infringement Lawsuit over Ethicon's Ultrasonic Surgical Devices
Covidien Files Patent Infringement Lawsuit over Ethicon's Ultrasonic Surgical Devices
HSMN NewsFeed - 1 May 2014
Rotation Medical Appoints Michael J. McNulty Vice President of Sales and Marketing
Rotation Medical Appoints Michael J. McNulty Vice President of Sales and Marketing
HSMN NewsFeed - 21 Feb 2014
Cordis Corporation Receives CE Mark for RENLANE(TM) Renal Denervation System to Treat Resistant Hypertension
Cordis Corporation Receives CE Mark for RENLANE(TM) Renal Denervation System to Treat Resistant Hypertension
HSMN NewsFeed - 10 Feb 2014
Sunesis Appoints Joseph I. DePinto as Chief Commercial Officer, Updates VALOR Timeline to Unblinding of Data
Sunesis Appoints Joseph I. DePinto as Chief Commercial Officer, Updates VALOR Timeline to Unblinding of Data
HSMN NewsFeed - 16 Jan 2014
Johnson & Johnson Announces Binding Offer From The Carlyle Group To Acquire Ortho-Clinical Diagnostics
Johnson & Johnson Announces Binding Offer From The Carlyle Group To Acquire Ortho-Clinical Diagnostics
HSMN NewsFeed - 13 Jan 2014
Align Technology Promotes Raphael Pascaud to Vice President International
Align Technology Promotes Raphael Pascaud to Vice President International
HSMN NewsFeed - 13 Jan 2014
Cardica Appoints Industry Veteran Liam Burns As Vice President, Sales And Marketing
Cardica Appoints Industry Veteran Liam Burns As Vice President, Sales And Marketing
HSMN NewsFeed - 6 Jan 2014
Kala Pharmaceuticals Appoints Howard B. Rosen as Chairman of the Board of Directors
Kala Pharmaceuticals Appoints Howard B. Rosen as Chairman of the Board of Directors
HSMN NewsFeed - 11 Dec 2013
Ethicon Receives 510(k) Clearance for New HARMONIC FOCUS(R)+ Shears with Adaptive Tissue Technology
Ethicon Receives 510(k) Clearance for New HARMONIC FOCUS(R)+ Shears with Adaptive Tissue Technology
HSMN NewsFeed - 9 Dec 2013
Hologic Appoints Stephen P. MacMillan President and Chief Executive Officer
Hologic Appoints Stephen P. MacMillan President and Chief Executive Officer
HSMN NewsFeed - 11 Nov 2013
Ethicon Energy Launches ENSEAL(R) G2 Articulating at AAGL Global Congress on Minimally Invasive Gynecology
Ethicon Energy Launches ENSEAL(R) G2 Articulating at AAGL Global Congress on Minimally Invasive Gynecology
HSMN NewsFeed - 29 Oct 2013
Ethicon Receives 510(k) Clearance of Ear, Nose and Throat (ENT) Indication for ENSEAL(R) Tissue Sealers
Ethicon Receives 510(k) Clearance of Ear, Nose and Throat (ENT) Indication for ENSEAL(R) Tissue Sealers
HSMN NewsFeed - 28 Oct 2013
Ethicon Receives 510(k) Clearance for New HARMONIC ACE(R)+ 7 Shears with Advanced Hemostasis
Ethicon Receives 510(k) Clearance for New HARMONIC ACE(R)+ 7 Shears with Advanced Hemostasis
HSMN NewsFeed - 18 Sep 2013
BioSig Technologies, Inc. Appoints David J. Drachman as Chief Executive Officer & Chairman
BioSig Technologies, Inc. Appoints David J. Drachman as Chief Executive Officer & Chairman
HSMN NewsFeed - 6 Sep 2013
Christopher Prentice to Lead Mazor Robotics’ U.S. Commercial Operations and Global Marketing Strategy
Christopher Prentice to Lead Mazor Robotics’ U.S. Commercial Operations and Global Marketing Strategy
HSMN NewsFeed - 22 Jul 2013
Endo Health Solutions Names Don DeGolyer Chief Operating Officer of Pharmaceuticals
Endo Health Solutions Names Don DeGolyer Chief Operating Officer of Pharmaceuticals
HSMN NewsFeed - 12 Jul 2013
Hospitals, Healthcare Providers to Benefit from a New Premier Agreement for Vascular Closure Devices
Hospitals, Healthcare Providers to Benefit from a New Premier Agreement for Vascular Closure Devices
HSMN NewsFeed - 17 Jun 2013
Johnson & Johnson Announces Definitive Agreement To Acquire Aragon Pharmaceuticals, Inc.
Johnson & Johnson Announces Definitive Agreement To Acquire Aragon Pharmaceuticals, Inc.
HSMN NewsFeed - 5 Jun 2013
Johnson & Johnson Innovation Announces Opening of the California Innovation Center
Johnson & Johnson Innovation Announces Opening of the California Innovation Center
HSMN NewsFeed - 28 May 2013
Kala Pharmaceuticals Appoints Charles McDermott as Executive Vice President of Business Development
Kala Pharmaceuticals Appoints Charles McDermott as Executive Vice President of Business Development
HSMN NewsFeed - 13 May 2013
Vision-Sciences Appoints Howard Zauberman as Interim Chief Executive Officer
Vision-Sciences Appoints Howard Zauberman as Interim Chief Executive Officer
HSMN NewsFeed - 7 May 2013
Coronado Biosciences Appoints Thomas F. Schaible, Ph.D. as Project Leader, Inflammatory Bowel Disease
Coronado Biosciences Appoints Thomas F. Schaible, Ph.D. as Project Leader, Inflammatory Bowel Disease
HSMN NewsFeed - 1 May 2013
Ultragenyx Appoints Eric Yuen, MD as Chief Medical Officer and Senior Vice President
Ultragenyx Appoints Eric Yuen, MD as Chief Medical Officer and Senior Vice President
HSMN NewsFeed - 22 Apr 2013
RXi Pharmaceuticals Appoints H. Paul Dorman and Curtis Lockshin, Ph.D. to Board of Directors
RXi Pharmaceuticals Appoints H. Paul Dorman and Curtis Lockshin, Ph.D. to Board of Directors
HSMN NewsFeed - 29 Mar 2013
Covidien Awarded $176.5 Million Verdict in Patent Litigation against Ethicon Endo-Surgery
Covidien Awarded $176.5 Million Verdict in Patent Litigation against Ethicon Endo-Surgery
HSMN NewsFeed - 6 Feb 2013
SpinalCyte, LLC Reports the Addition of Jeffrey Geesin, Ph.D. to Clinical Advisory Board
SpinalCyte, LLC Reports the Addition of Jeffrey Geesin, Ph.D. to Clinical Advisory Board
HSMN NewsFeed - 4 Feb 2013
Ethicon Receives 510(k) Clearance for ENSEAL(R) G2 Articulating Tissue Sealer
Ethicon Receives 510(k) Clearance for ENSEAL(R) G2 Articulating Tissue Sealer
HSMN NewsFeed - 18 Dec 2012
Celator(R) Pharmaceuticals Announces Appointment of Fred Powell as Chief Financial Officer
Celator(R) Pharmaceuticals Announces Appointment of Fred Powell as Chief Financial Officer
HSMN NewsFeed - 27 Nov 2012
Kala Pharmaceuticals Appoints Dr. Bernard Gilly to Its Board of Directors
Kala Pharmaceuticals Appoints Dr. Bernard Gilly to Its Board of Directors
HSMN NewsFeed - 19 Nov 2012
Echo Therapeutics Hires Daniel Sunday as Vice President of Manufacturing and Global Supply Chain
Echo Therapeutics Hires Daniel Sunday as Vice President of Manufacturing and Global Supply Chain
HSMN NewsFeed - 16 Nov 2012
Saladax Biomedical, Inc. Appoints Mark D. Myslinski as Chief Commercial Officer
Saladax Biomedical, Inc. Appoints Mark D. Myslinski as Chief Commercial Officer
HSMN NewsFeed - 12 Oct 2012
Accuray Incorporated CEO Resigns, Board Appoints Successor for Next Phase of Growth
Accuray Incorporated CEO Resigns, Board Appoints Successor for Next Phase of Growth
HSMN NewsFeed - 26 Jul 2012
Endocyte Appoints David Meek to Newly Created Position of Chief Commercial Officer
Endocyte Appoints David Meek to Newly Created Position of Chief Commercial Officer
HSMN NewsFeed - 24 Jul 2012
Oncothyreon Appoints Guy Cipriani as Vice President, Business Development
Oncothyreon Appoints Guy Cipriani as Vice President, Business Development
HSMN NewsFeed - 24 Jul 2012
Relmada Therapeutics Raises $3.0 Million In Initial Closing Of Series A Financing
Relmada Therapeutics Raises $3.0 Million In Initial Closing Of Series A Financing
HSMN NewsFeed - 12 Jul 2012
Kala Pharmaceuticals Appoints Guillaume Pfefer, PhD as President and Chief Executive Officer
Kala Pharmaceuticals Appoints Guillaume Pfefer, PhD as President and Chief Executive Officer
HSMN NewsFeed - 10 Jul 2012
First Patient Treated in Landmark U.S. Randomized Pivotal Trial of Nevro’s Chronic Pain Treatment
First Patient Treated in Landmark U.S. Randomized Pivotal Trial of Nevro’s Chronic Pain Treatment
HSMN NewsFeed - 21 Jun 2012
Nile Therapeutics Appoints Darlene Horton, M.D., as Chief Medical Officer
Nile Therapeutics Appoints Darlene Horton, M.D., as Chief Medical Officer
HSMN NewsFeed - 10 May 2012
RXi Pharmaceuticals Appoints Industry Veteran Dr. Geert Cauwenbergh as President and Chief Executive Officer
RXi Pharmaceuticals Appoints Industry Veteran Dr. Geert Cauwenbergh as President and Chief Executive Officer
HSMN NewsFeed - 7 May 2012
New Biologics Company, Bioventus, Launches with Focus on Active Orthopaedic Healing
New Biologics Company, Bioventus, Launches with Focus on Active Orthopaedic Healing
HSMN NewsFeed - 3 May 2012
Johnson & Johnson (China) Investment Ltd. Acquires Guangzhou Bioseal Biotechnology Co., Ltd.
Johnson & Johnson (China) Investment Ltd. Acquires Guangzhou Bioseal Biotechnology Co., Ltd.
HSMN NewsFeed - 24 Apr 2012
Genta Appoints Dr. Brian Leyland-Jones and Richard J. Moran to Its Board of Directors
Genta Appoints Dr. Brian Leyland-Jones and Richard J. Moran to Its Board of Directors
HSMN NewsFeed - 19 Mar 2012
ZELTIQ Aesthetics, Inc. Names Mike Genau President of Its North American Franchise
ZELTIQ Aesthetics, Inc. Names Mike Genau President of Its North American Franchise
HSMN NewsFeed - 16 Mar 2012
Avanir Pharmaceuticals Announces Appointment of Rohan Palekar as Chief Commercial Officer
Avanir Pharmaceuticals Announces Appointment of Rohan Palekar as Chief Commercial Officer
HSMN NewsFeed - 14 Feb 2012
Bioheart Acquires Exclusive Rights to Ageless Regenerative Institute's Adipose Cell Technology
Bioheart Acquires Exclusive Rights to Ageless Regenerative Institute's Adipose Cell Technology
HSMN NewsFeed - 13 Feb 2012
AxoGen Names Jill Schiaparelli Senior Vice President of Business Strategy & Marketing
AxoGen Names Jill Schiaparelli Senior Vice President of Business Strategy & Marketing
HSMN NewsFeed - 20 Jan 2012
La Jolla Pharmaceutical Company Acquires GCS-100, a First-in-Class Galectin-3 Antagonist
La Jolla Pharmaceutical Company Acquires GCS-100, a First-in-Class Galectin-3 Antagonist
HSMN NewsFeed - 12 Jan 2012
Biosense Webster Announces FDA approval of the THERMOCOOL(R) SF Catheter in the United States
Biosense Webster Announces FDA approval of the THERMOCOOL(R) SF Catheter in the United States
HSMN NewsFeed - 12 Dec 2011
Symmetry Medical to Acquire the Surgical Instruments Business of Codman & Shurtleff
Symmetry Medical to Acquire the Surgical Instruments Business of Codman & Shurtleff
HSMN NewsFeed - 7 Nov 2011
Vascular Dynamics Names Former Micrus Endovascular President Robert Stern as President and CEO
Vascular Dynamics Names Former Micrus Endovascular President Robert Stern as President and CEO
HSMN NewsFeed - 7 Nov 2011
IntraPace Introduces New Lead For abiliti(R) System Resulting in Reduced Procedure Time
IntraPace Introduces New Lead For abiliti(R) System Resulting in Reduced Procedure Time
HSMN NewsFeed - 31 Oct 2011
NeurogesX Appoints Dr. Stephen J. Peroutka as Executive Vice President and Chief Medical Officer
NeurogesX Appoints Dr. Stephen J. Peroutka as Executive Vice President and Chief Medical Officer
HSMN NewsFeed - 11 Oct 2011
iScience Interventional Receives Investment Which Accelerates Microcatheter Commercialization Activities
iScience Interventional Receives Investment Which Accelerates Microcatheter Commercialization Activities
HSMN NewsFeed - 13 Sep 2011
Boston Scientific Names Michael F. Mahoney as Company President, Announces CEO Transition Plan
Boston Scientific Names Michael F. Mahoney as Company President, Announces CEO Transition Plan
HSMN NewsFeed - 25 Aug 2011
Celsion Announces the Appointment of Gary Renshaw, D.O., as Executive Medical Director
Celsion Announces the Appointment of Gary Renshaw, D.O., as Executive Medical Director
HSMN NewsFeed - 23 Aug 2011
Relievant Medsystems Appoints Alex M. DiNello as President and Chief Executive Officer
Relievant Medsystems Appoints Alex M. DiNello as President and Chief Executive Officer
HSMN NewsFeed - 28 Jul 2011
Ramona M. Lloyd, Ph.D., RAC, Joins Omthera Pharmaceuticals as Vice President Regulatory Affairs
Ramona M. Lloyd, Ph.D., RAC, Joins Omthera Pharmaceuticals as Vice President Regulatory Affairs
HSMN NewsFeed - 15 Jul 2011
Janssen Pharmaceuticals, Inc. Announces Definitive Agreement to Divest Ortho Dermatologics Division
Janssen Pharmaceuticals, Inc. Announces Definitive Agreement to Divest Ortho Dermatologics Division
HSMN NewsFeed - 27 Jun 2011
Arno Therapeutics Names Alexander Zukiwski, M.D., Vice President and Chief Medical Officer
Arno Therapeutics Names Alexander Zukiwski, M.D., Vice President and Chief Medical Officer
HSMN NewsFeed - 15 Jun 2011
Johnson & Johnson Announces Special Charge Related to Restructuring Plans for Cordis Corporation Subsidiary
Johnson & Johnson Announces Special Charge Related to Restructuring Plans for Cordis Corporation Subsidiary
HSMN NewsFeed - 15 Jun 2011
Cordis Announces Discontinuation of NEVO Sirolimus-Eluting Coronary Stent
Cordis Announces Discontinuation of NEVO Sirolimus-Eluting Coronary Stent
HSMN NewsFeed - 8 Jun 2011
Boston Scientific Announces Favorable Appellate Court Ruling Affirming Invalidity of J&J Patents
Boston Scientific Announces Favorable Appellate Court Ruling Affirming Invalidity of J&J Patents
HSMN NewsFeed - 28 Apr 2011
Arno Therapeutics Announces the Appointment of Mr. Glenn Mattes as President and Chief Executive Officer
Arno Therapeutics Announces the Appointment of Mr. Glenn Mattes as President and Chief Executive Officer
HSMN NewsFeed - 15 Apr 2011
Johnson & Johnson Provides Additional Information Regarding Amended Agreement With Merck
Johnson & Johnson Provides Additional Information Regarding Amended Agreement With Merck
HSMN NewsFeed - 4 Apr 2011
Cameron Health Appoints Ward Dykstra as Vice President of Global Marketing
Cameron Health Appoints Ward Dykstra as Vice President of Global Marketing
HSMN NewsFeed - 21 Mar 2011
Cordis Demonstrates Commitment to Advancing Therapies for Below-the-Knee Vascular Disease
Cordis Demonstrates Commitment to Advancing Therapies for Below-the-Knee Vascular Disease
HSMN NewsFeed - 21 Mar 2011
Lithera Announces the Appointment of George W. Mahaffey as President and Chief Executive Officer
Lithera Announces the Appointment of George W. Mahaffey as President and Chief Executive Officer
HSMN NewsFeed - 21 Mar 2011
Selventa Names John Tagliamonte as Senior Vice President of Corporate Development
Selventa Names John Tagliamonte as Senior Vice President of Corporate Development
HSMN NewsFeed - 23 Feb 2011
Court of Appeals Overturns $1.8 Billion Patent Verdict for Centocor Ortho Biotech Inc.
Court of Appeals Overturns $1.8 Billion Patent Verdict for Centocor Ortho Biotech Inc.
HSMN NewsFeed - 7 Feb 2011
ReVision Optics Announces the Appointment of John T. Kilcoyne as CEO and President
ReVision Optics Announces the Appointment of John T. Kilcoyne as CEO and President
HSMN NewsFeed - 10 Jan 2011
Symmetry Medical Board of Directors Appoints Thomas J. Sullivan President and Chief Executive Officer
Symmetry Medical Board of Directors Appoints Thomas J. Sullivan President and Chief Executive Officer
HSMN NewsFeed - 4 Jan 2011
Accomplished Sales and Marketing Executive Joins OraSure Technologies Management Team
Accomplished Sales and Marketing Executive Joins OraSure Technologies Management Team
HSMN NewsFeed - 2 Dec 2010
PhaseBio Pharmaceuticals Reaches Key Milestones and Receives $15 Million to Complete Series B Financing
PhaseBio Pharmaceuticals Reaches Key Milestones and Receives $15 Million to Complete Series B Financing
HSMN NewsFeed - 1 Dec 2010
Delcath Names Bernard R. Tyrrell as Senior Vice President for North American Sales and Marketing
Delcath Names Bernard R. Tyrrell as Senior Vice President for North American Sales and Marketing
HSMN NewsFeed - 1 Nov 2010
Ortho Clinical Diagnostics Receives FDA Clearance for Intact Parathyroid Hormone Assay
Ortho Clinical Diagnostics Receives FDA Clearance for Intact Parathyroid Hormone Assay
HSMN NewsFeed - 11 Oct 2010
Alphatec Holdings Announces Appointment of Michael O'Neill, FCMA, as Chief Financial Officer
Alphatec Holdings Announces Appointment of Michael O'Neill, FCMA, as Chief Financial Officer
HSMN NewsFeed - 30 Sep 2010
CYPHER(R) Sirolimus Drug-Eluting Stent Remains Unsurpassed in Terms of Clinical Safety and Efficacy
CYPHER(R) Sirolimus Drug-Eluting Stent Remains Unsurpassed in Terms of Clinical Safety and Efficacy
HSMN NewsFeed - 27 Sep 2010
SCOLR Pharma, Inc. Names Carl Johnson as Chairman; Former Chairman Michael Taglich Remains as Director
SCOLR Pharma, Inc. Names Carl Johnson as Chairman; Former Chairman Michael Taglich Remains as Director
HSMN NewsFeed - 1 Sep 2010
Inspire Names Robert Savel as Senior Vice President and Chief Technical Officer
Inspire Names Robert Savel as Senior Vice President and Chief Technical Officer
HSMN NewsFeed - 31 Aug 2010
CORDIS Announces Results of Ten-Year CYPHER(R) Sirolimus-Eluting Coronary Stent Follow-Up
CORDIS Announces Results of Ten-Year CYPHER(R) Sirolimus-Eluting Coronary Stent Follow-Up
HSMN NewsFeed - 22 Jul 2010
Richard B. Brewer Joins Nile Therapeutics as Executive Chairman of the Board of Directors
Richard B. Brewer Joins Nile Therapeutics as Executive Chairman of the Board of Directors
HSMN NewsFeed - 12 Jul 2010
Johnson & Johnson Announces Definitive Agreement to Acquire Micrus Endovascular
Johnson & Johnson Announces Definitive Agreement to Acquire Micrus Endovascular
HSMN NewsFeed - 12 Jul 2010
Ethicon Endo-Surgery Completes Divestiture of Breast Care Business to Devicor Medical Products
Ethicon Endo-Surgery Completes Divestiture of Breast Care Business to Devicor Medical Products
HSMN NewsFeed - 7 Jul 2010
K-V Pharmaceutical Company Announces the Election of New Independent Member to Board of Directors
K-V Pharmaceutical Company Announces the Election of New Independent Member to Board of Directors
HSMN NewsFeed - 1 Jul 2010
Symmetry Medical Appoints Jose Fernandez Senior Vice President of New Product Development
Symmetry Medical Appoints Jose Fernandez Senior Vice President of New Product Development
HSMN NewsFeed - 18 Jun 2010
Vertos Medical Expands Executive Team Amidst Growing Commercial Acceptance of mild(R)
Vertos Medical Expands Executive Team Amidst Growing Commercial Acceptance of mild(R)
HSMN NewsFeed - 1 Jun 2010
Centocor Ortho Biotech Inc. Acquires RespiVert Ltd., Strengthens Pulmonary Focus
Centocor Ortho Biotech Inc. Acquires RespiVert Ltd., Strengthens Pulmonary Focus
HSMN NewsFeed - 24 May 2010
IDEV Technologies Names Veteran Healthcare Executive Dennis Donohoe, M.D. Chief Medical Officer
IDEV Technologies Names Veteran Healthcare Executive Dennis Donohoe, M.D. Chief Medical Officer
HSMN NewsFeed - 20 May 2010
AngioDynamics Appoints Lynda Wallace Senior Vice President of Business Development
AngioDynamics Appoints Lynda Wallace Senior Vice President of Business Development
HSMN NewsFeed - 13 May 2010
Biosense Webster Introduces the THERMOCOOL(R) SF Irrigated Catheter in the European Union
Biosense Webster Introduces the THERMOCOOL(R) SF Irrigated Catheter in the European Union
HSMN NewsFeed - 13 May 2010
Biosense Webster Reinforces Its Leadership Position in the Electrophysiology Market at Heart Rhythm 2010
Biosense Webster Reinforces Its Leadership Position in the Electrophysiology Market at Heart Rhythm 2010
HSMN NewsFeed - 10 May 2010
AltheaDx Announces Appointment of New CEO and President and Adds Dr. Ann Kessler to the Board of Directors
AltheaDx Announces Appointment of New CEO and President and Adds Dr. Ann Kessler to the Board of Directors
HSMN NewsFeed - 3 May 2010
VIVUS Appoints Michael Miller to Senior Vice President and Chief Commercial Officer
VIVUS Appoints Michael Miller to Senior Vice President and Chief Commercial Officer
HSMN NewsFeed - 23 Apr 2010
InteKrin Therapeutics Appoints Roman Skowronski, MD, PhD as Vice President of Clinical Development
InteKrin Therapeutics Appoints Roman Skowronski, MD, PhD as Vice President of Clinical Development
HSMN NewsFeed - 21 Apr 2010
KCI Appoints Kien Nguyen Vice President of Global Marketing for Active Healing Solutions
KCI Appoints Kien Nguyen Vice President of Global Marketing for Active Healing Solutions
Additional items found! 500
Members Archive contains
500 additional stories matching:
Johnson & Johnson
(Password required)
Johnson & Johnson
(Password required)
